Keywords: ranbaxy, Synriam, Malaria drug, Launched in India, Daiichi Sankyo

Ranbaxy debuts first Indian-developed malaria drug, Synriam

Article | 27 April 2012

Print This

Indian drug major Ranbaxy (AB: B) said yesterday - coinciding with World Malaria Day - that it is “opening ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in